Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Feser

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The Canadian Nurse|January 4, 2001
A collaborative approach to pain assessmentS Huber, L Feser, D Hughes
Practical Laboratory Medicine|August 20, 2024
A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritisHeather A Nelson, Dipanwita Banerjee, Camille L Novis, et al.
Journal of Autoimmunity|March 13, 2021
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritisBhargavi Duvvuri, Al Anoud Baddour, Kevin D Deane, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Detecting change-points in preclinical rheumatoid arthritis biomarkers using Bayesian multivariate segmented regressionYonatan F Wolde, Alexandria M Jensen, Brandie D Wagner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2022
Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid ArthritisRichard E Moore, Ting Wang, Bhargavi Duvvuri, et al.
ACR Open Rheumatology|September 16, 2022
Preferences and Insights for Participation in a Rheumatoid Arthritis Clinical Prevention Trial: A Mixed-Methods StudyChelsie L Fleischer, Elizabeth A Bemis, Marie L Feser, et al.
Molecular Immunology|June 18, 2019
Complement and its environmental determinants in the progression of human rheumatoid arthritisElizabeth A Bemis, Jill M Norris, Jennifer Seifert, et al.
Frontiers in Immunology|April 9, 2020
Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid ArthritisPrathapan Ayyappan, Robert Z Harms, Jennifer A Seifert, et al.
Rheumatology (Oxford, England)|October 14, 2017
The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive populationRyan W Gan, Elizabeth A Bemis, M Kristen Demoruelle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2026
Increased plasma microbial tDR-1 in at-risk individuals is associated with decreased conversion to clinical rheumatoid arthritis and reduces an in vitro macrophage type 1 interferon responseAnastasiia Phothisane, Tulsi K Joishy, Carolina Ramirez-Becerra, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Canadian Nurse|January 4, 2001
A collaborative approach to pain assessmentS Huber, L Feser, D Hughes
Practical Laboratory Medicine|August 20, 2024
A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritisHeather A Nelson, Dipanwita Banerjee, Camille L Novis, et al.
Journal of Autoimmunity|March 13, 2021
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritisBhargavi Duvvuri, Al Anoud Baddour, Kevin D Deane, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Detecting change-points in preclinical rheumatoid arthritis biomarkers using Bayesian multivariate segmented regressionYonatan F Wolde, Alexandria M Jensen, Brandie D Wagner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2022
Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid ArthritisRichard E Moore, Ting Wang, Bhargavi Duvvuri, et al.
ACR Open Rheumatology|September 16, 2022
Preferences and Insights for Participation in a Rheumatoid Arthritis Clinical Prevention Trial: A Mixed-Methods StudyChelsie L Fleischer, Elizabeth A Bemis, Marie L Feser, et al.
Molecular Immunology|June 18, 2019
Complement and its environmental determinants in the progression of human rheumatoid arthritisElizabeth A Bemis, Jill M Norris, Jennifer Seifert, et al.
Frontiers in Immunology|April 9, 2020
Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid ArthritisPrathapan Ayyappan, Robert Z Harms, Jennifer A Seifert, et al.
Rheumatology (Oxford, England)|October 14, 2017
The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive populationRyan W Gan, Elizabeth A Bemis, M Kristen Demoruelle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2026
Increased plasma microbial tDR-1 in at-risk individuals is associated with decreased conversion to clinical rheumatoid arthritis and reduces an in vitro macrophage type 1 interferon responseAnastasiia Phothisane, Tulsi K Joishy, Carolina Ramirez-Becerra, et al.
Pageof 4